Test Price
2,800 AED✅ Home Collection Available
NBAS Gene Infantile Liver Failure Syndrome Type 2 Genetic Test in UAE | AED 2800 | DHA Compliant
Executive Summary & Core Metrics
- 99.9% diagnostic sensitivity via ISO 9001:2015 certified processing.
- Home blood collection available daily 8 AM–11 PM with VIP Mobile Phlebotomy and temperature‑controlled cold chain.
- Post‑result telephonic medical consultation to help interpret findings.
- Direct insurance verification and billing support via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This next‑generation sequencing (NGS) test analyzes the entire coding region of the NBAS gene to identify pathogenic variants responsible for Infantile Liver Failure Syndrome Type 2 (ILFS2) – a life‑threatening autosomal recessive disorder characterized by recurrent acute liver failure episodes triggered by fever. In the UAE, the test is performed under DHA‑approved facility # 1143 with ISO 9001:2015 certification, delivering a diagnostic sensitivity of 99.9% and aiding in early clinical intervention, family counseling, and personalized management plans.
| Feature | Our Test (NGS – NBAS Full Gene) | Alternative (Single‑Variant/Microarray) |
|---|---|---|
| Precision | 99.9% analytic sensitivity for all exonic & splice‑site NBAS variants | May miss rare or novel variants; limited to known hotspots |
| Methodology | Next‑Generation Sequencing (NGS) with deep bioinformatics analysis & ACMG classification | Sanger sequencing or array‑based screening |
| Turnaround | 3–4 weeks (includes confirmatory analysis) | 2–6 weeks, often without in‑depth variant interpretation |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I emphasize that the NBAS test is critical for confirming ILFS2, but it must be interpreted in the context of the full clinical picture, including acute liver function markers and a detailed family history. A negative result does not rule out other metabolic causes; ongoing follow‑up with a pediatric hepatologist is essential."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠️ Medication Notice: Do not discontinue prescribed medications (e.g., supportive liver therapy, antipyretics) without explicit advice from your treating physician. Genetic testing alone cannot guide acute therapy decisions.
Safety Exclusion Criteria & Emergency Red Flags
- Not for acute life‑threatening episodes: Do not delay emergency care for a child with jaundice, coagulopathy, or encephalopathy to obtain this test.
- Minors must have legal guardian consent in compliance with UAE PDPL and Federal Law No. 2 of 2019 on health data; unaccompanied minors will be refused.
- Prior genetic counseling mandatory: Without a certified genetic counseling session and documented pedigree chart, sample submission will not be processed.
- Sample integrity: Whole blood must be collected in EDTA tubes; FTA cards must be clean, dry, and properly sealed.
- Red Flag (Emergency): If the patient develops sudden vomiting, lethargy, hypoglycemia, or liver‑derived coagulopathy, proceed immediately to the nearest hospital ER. Do not wait for genetic results.
Patient FAQ & Clinical Guidance
1. Why does the NBAS test take 3–4 weeks, and can the result be expedited?
NGS sequencing generates gigabytes of data requiring meticulous bioinformatics alignment, variant calling, and manual curation — a multi‑step quality‑assured process ensuring 99.9% accuracy, which cannot be safely shortened.
2. Do I need special preparation or fasting before the blood draw?
No fasting or dietary restrictions are required; a simple blood draw (or finger‑prick for FTA card) can be performed anytime. Keep the child well‑hydrated.
3. Will this test reveal other diseases or genetic risks beyond ILFS2?
Our analysis strictly targets the NBAS gene with 99.9% analytical specificity and does not interrogate unrelated genes, so incidental findings are extremely rare and reported only if clinically actionable under UAE guidelines.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This service adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing and patient consent comply with Federal Decree‑Law No. 4 of 2016 on Medical Liability. Sample processing is conducted in an ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139) at DNA Labs UAE, DHA License No. 1143.
Contact for Bookings & Insurance Verification: +971 54 548 8731 (WhatsApp)
Clinical & Logistical Metadata
| Test Name | NBAS Gene Infantile Liver Failure Syndrome Type 2 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA) or FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) with deep bioinformatics analysis and ACMG classification |
| ICD-10-CM Code | K72.00 |
| LOINC Code | 101328-1 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians